Unichem Pharmaceuticals USA Inc. is recalling 18,960 bottles of Clonidine Hydrochloride (clonidine) tablets because bottles labeled as the 0.3 mg strength may actually contain 0.2 mg strength tablets. The recall affects 100-count bottles from lot GCLH22005 with an expiration date of February 2024. No incidents or injuries have been reported to date regarding this mix-up.
A mix-up in medication strength means consumers may receive a lower dose of clonidine than prescribed. This could lead to poorly controlled blood pressure and potential health complications from under-treatment.
You have 2 options:
Recall #: D-1541-2022. Bottled labeled as 0.3 mg may contain 0.2 mg strength tablets.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.